New York, NY -- (SBWIRE) -- 01/29/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Penn West Petroleum Ltd (USA) (NYSE:PWE), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Delcath Systems, Inc (NASDAQ:DCTH), McEwen Mining Inc (NYSE:MUX)
Penn West Petroleum Ltd (USA) (NYSE:PWE) showed a volume of 2.22 million shares by the end of last trade whereas the average volume of the stock remained 2.53 million shares. The stock opened the session at $7.27 but then moved to $7.33. At that price, the stock showed a positive performance of 0.69%. Penn West Petroleum Ltd. (Penn West), formerly Penn West Energy Trust, is a Canadian exploration and production company. Penn West is engaged in the business of acquiring, exploring, developing, exploiting and holding interests in petroleum and natural gas properties and related assets.
Will PWE Continue To Move Higher? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) opened the session at $3.40 and closed the session at $3.55. The stock showed a positive performance of 5.65% in previous trading session. Traded with volume of 2.22 million shares in the prior session and the average volume of the stock remained 2.86 million shares. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system.
For How Long AVNR will fight for Profitability? Read This Trend Analysis report
Delcath Systems, Inc (NASDAQ:DCTH) opened the session at $0.32 and closed the session at $0.330. The stock showed a positive performance of 6.28% in previous trading session. Traded with volume of 2.22 million shares in the prior session and the average volume of the stock remained 6.05 million shares. The beta of the stock remained 2.06. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system.
Why Should Investors Buy DCTH After The Recent Gain? Just Go Here and Find Out
McEwen Mining Inc (NYSE:MUX) the stock advanced 3.23% and finished the session at $2.56. Traded with volume of 2.20 million shares in the prior session and the average volume of the stock remained 2.59 million shares. The beta of the stock remained -0.28. McEwen Mining Inc. (McEwen Mining), formerly US Gold Corporation, is engaged in the exploration for and production of precious metals in the United States, Mexico and Argentina. McEwen Mining’s operating segments include USA and Mexico.
Will MUX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)